SpreeHealth
Drug price

Enalapril: here's the fair price

This is what US pharmacies pay, on average, for enalapril. Use it to spot a fair cash price, and feel good about asking for one.

Lowest generic tablet or capsule

Enalapril Maleate 2.5 Mg Tab

$1.88
pharmacy cost for 30

A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.

Your best move

Ask for generic Enalapril Maleate 2.5 Mg Tab. Pharmacies pay about $1.88 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.

Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.

Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.

Pharmacies near you

Your ZIP and location stay in your browser. We never store them.

Every strength and form

ProductPharmacy cost30 countEffective
ENALAPRIL MALEATE 2.5 MG TABGeneric$0.06
per tablet or capsule
$1.8810/21/2026
ENALAPRIL MALEATE 10 MG TABGeneric$0.07
per tablet or capsule
$2.0810/21/2026
ENALAPRIL MALEATE 5 MG TABLETGeneric$0.08
per tablet or capsule
$2.5410/21/2026
ENALAPRIL MALEATE 20 MG TABGeneric$0.10
per tablet or capsule
$2.8810/21/2026
ENALAPRIL 1 MG/ML ORAL SOLNGeneric$0.83
per mL
n/a10/21/2026

Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.

Label basics

What it is used for (FDA label)

INDICATIONS AND USAGE Hypertension Enalapril maleate is indicated for the treatment of hypertension. Enalapril maleate is effective alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. The blood pressure lowering effects of enalapril maleate and thiazides are approximately additive. Heart Failure Enalapril maleate is indicated for the treatment of symptomatic congestive heart failure, usually in combination with diuretics and digitalis. In these patients enalapril maleate improves symptoms, increases survival, and decreases the frequency of hospitalization (see CLINICAL PHARMACOLOGY, Heart Failure, Mortality Trials for details and limitations of...

Boxed warning (from the label): WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue enalapril maleate as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (See WARNINGS: Fetal Toxicity .)

Common side effects (FDA label)

ADVERSE REACTIONS Enalapril maleate has been evaluated for safety in more than 10,000 patients, including over 1000 patients treated for one year or more. Enalapril maleate has been found to be generally well tolerated in controlled clinical trials involving 2987 patients. For the most part, adverse experiences were mild and transient in nature. In clinical trials, discontinuation of therapy due to clinical adverse experiences was required in 3.3 percent of patients with hypertension and in 5.7 percent of patients with heart failure. The frequency of adverse experiences was not related to...

Drug interactions (from the label)

Drug Interactions Neprilysin Inhibitors Patients taking concomitant neprilysin inhibitors may be at increased risk for angioedema (see WARNINGS ). Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy. In general, avoid combined use of RAS inhibitors. Closely monitor blood pressure, renal function, and electrolytes in patients on...

Warnings (from the label)

WARNINGS Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including enalapril maleate) may be subject to a variety of adverse reactions, some of them serious. Head and Neck Angioedema Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported in patients treated with angiotensin-converting enzyme inhibitors, including enalapril maleate. This may occur at any time during treatment. In such cases enalapril maleate should be promptly discontinued and appropriate therapy and monitoring...

Source: FDA drug label via openFDA, label effective 2026-07-28. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.